IMMUNIC, INC. (IMUX)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$103.23M | -$98.05M | -$99.22M | -$119.49M | -$91.67M | -$48.97M | -$37.03M | -$12.00M | -$52.66M | -$41.27M |
| Net Income | -$97.17M | -$100.51M | -$93.61M | -$120.41M | -$92.94M | -$44.02M | -$34.93M | -$11.54M | -$52.08M | -$40.97M |
| EPS (Diluted) | $-0.62 | $-1.00 | $-2.11 | $-3.78 | $-3.93 | $-2.81 | — | — | — | — |
| Total Assets | $24.05M | $40.87M | $54.30M | $127.75M | $139.10M | $167.86M | $65.95M | $13.37M | $60.38M | $64.03M |
| Total Liabilities | $30.73M | $22.44M | $25.37M | $14.07M | $11.98M | $9.08M | $7.59M | $1.92M | — | — |
| Shareholders' Equity | -$6.67M | $18.43M | $28.93M | $113.68M | $127.11M | $158.78M | $58.36M | -$25.74M | -$13.34M | $58.45M |
| Cash & Equivalents | $15.48M | $35.67M | $46.67M | $106.75M | $86.86M | $127.45M | $29.37M | $13.07M | $56.90M | $59.99M |
| Operating Cash Flow | -$85.81M | -$84.77M | -$70.83M | -$65.14M | -$83.23M | -$46.12M | -$28.55M | -$9.74M | -$40.40M | -$35.77M |
| Capital Expenditures | $161.0K | $264.0K | $334.0K | $112.0K | $67.0K | $146.0K | $55.0K | $32.0K | $685.0K | $556.0K |
| Shares Outstanding | 90.15M | 90.15M | 45.18M | 39.31M | 26.34M | 21.17M | 10.74M | 847.0K | 42.37M | 32.14M |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — |